• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

204.79 +0.48 (+0.23%)
Official Closing Price Updated: 4:10 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,107,131
Open 204.60
Bid (Size) 204.51 (500)
Ask (Size) 205.53 (100)
Prev. Close 204.31
Today's Range 204.12 - 206.71
52wk Range 140.68 - 215.19
Shares Outstanding 2,628,679,824
Dividend Yield 2.54%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Harvard’s CHIEF AI: The ‘Swiss Army Knife’ of Pathology Achieving 98% Accuracy in Cancer Diagnosis
Today 14:54 EST
In a landmark achievement for computational medicine, researchers at Harvard Medical School have developed a "generalist" artificial intelligence model that is fundamentally reshaping the landscape of... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment ↗
Today 13:42 EST
Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE. 
Via Benzinga

Performance

YTD
-1.2%
-1.2%
1 Month
+1.6%
+1.6%
3 Month
+8.8%
+8.8%
6 Month
+31.9%
+31.9%
1 Year
+42.6%
+42.6%

More News

Read More
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
Today 10:22 EST
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗
January 05, 2026
Via MarketBeat
Topics Artificial Intelligence Death
News headline image
3 High-Yielding Dividend Kings to Buy in January for Safe Passive Income in 2026 and Beyond ↗
January 05, 2026
Via The Motley Fool
News headline image
2 Healthcare Stocks to Buy in a Bear Market ↗
January 03, 2026
Via The Motley Fool
Topics Economy
News headline image
Dividend Growers: 3 Stocks That Could Be Worth $1 Million in 36 Years. ↗
January 03, 2026
Via The Motley Fool
News headline image
Santa’s Empty Sleigh: Why the 2025 Rally Failure Signals a Rough Q1 for Wall Street
January 02, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
January 02, 2026
Via MarketMinute
Topics Economy Intellectual Property World Trade
News headline image
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
January 02, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Near Year High ↗
January 01, 2026
Via Talk Markets
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Right Now ↗
January 01, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
S&P 500 Eyes 7,000 Milestone: Technical Breakout Sets the Stage for a High-Stakes 2026
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Palantir Shares Retreat to $180.80 as Hawkish Fed Minutes and Institutional Rebalancing Cool Year-End Rally
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
News headline image
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
December 30, 2025
Via MarketMinute
Topics Product Recall
News headline image
The S&P 500 Seesaw: Analyzing IVV’s Year-End Turbulence After a Record-Breaking 2025
December 30, 2025
Via MarketMinute
Topics ETFs Economy Retirement
News headline image
Wall Street Stumbles at the Finish Line: S&P 500 and Nasdaq Fight to Break 3-Day Slide Amid Year-End Rebalancing
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever ↗
December 30, 2025
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Could These 3 "Recession-Proof" Dividend Stocks Surge 100% by 2031? ↗
December 29, 2025
Via The Motley Fool
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Santa Claus Stumble: Markets Pivot from Record Highs to Year-End Consolidation
December 29, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Price of Prosperity: Navigating the S&P 500’s Historic Valuation Peak as 2026 Dawns
December 29, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Earnings

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 204.79
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 01/06/26 04:10 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 538.33B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 538B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap